Digital Biomarker portfolio

IBDigital coordinates multipartner digital biomarker development in IBD to enable early prediction of flare ups through integrated, patient centred data collection.

Digital biomarkers for frailty and disease progression in liver cirrhosis via continuous wearable monitoring for early detection of clinical deterioration.

Promoting early Alzheimer’s detection through digital health tools, helping people and families spot cognitive decline and seek diagnosis.

Improving real-world treatment monitoring in obstructive sleep apnoea using continuous multimodal and patient-centred digital data.

Personalised cardiovascular care using digital biomarkers that combine real-world and clinical data to improve risk assessment, monitoring and prevention for individual patients.

Digital biomarkers for monitoring rheumatoid arthritis, enabling early detection of disease activity and supporting personalised treatment.

Patient-driven digital biomarkers for chronic disease management through co-creation, embedding patient priorities to ensure relevance, acceptability and usability.

Early detection of heart failure decompensation through continuous wearable monitoring and data-driven algorithms.

Digital biomarkers for type 2 diabetes prevention and management through personalised sensor, clinical, and behavioural assessments.

Optimising digital sleep monitoring with a standardised, device-agnostic framework for clinically validated sleep–wake detection from wearable motion data.